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The aspartic protease cathepsin E has been shown to induce apoptosis in cancer cells under physiological conditions. Therefore,
cathepsin E-activity-enhancing peptides functioning in the physiological pH range are valuable potential cancer therapeutic
candidates. Here, we have used a general in vitro selection method (evolutionary rapid panning analysis system (eRAPANSY)),
based on inverse substrate-function link (SF-link) selection to successfully identify cathepsin E-activity-enhancing peptide
aptamers at neutral pH. A successive enrichment of peptide activators was attained in the course of selection. One such peptide
activated cathepsin E up to 260%, had a high aﬃnity (KD; ∼300nM), and had physiological activity as demonstrated by its
apoptosis-inducing reaction in cancerous cells. This method is expected to be widely applicable for the identiﬁcation of protease-
activity-enhancing peptide aptamers.
1.Introduction
Besides other targets like kinases and membrane receptors,
proteases are one of the most eﬀective targets for drug
discovery [1, 2]. To date, protease-inhibitors have been
widely developed whereas protease-activators, which have
great potential in medical and scientiﬁc uses [3, 4], have
beenfar lessdeveloped due to technical diﬃculties [5]. These
include the fact that the activation mechanism, which is
usually regulated by the binding of ligands, that is, allosteric
eﬀectors, rather than by substrates [6], is very diﬃcult to
predict in detail from theory. In contrast, the inhibition
mechanism can be principally assigned to competitive
binding of inhibitors to the active site or steric hindrance of
the normal action of enzyme. The latter can be inferred from
the molecular structure at atomic resolution [7, 8].
To address the above diﬃculty, we have recently devel-
opedasystemicinvitroevolutionmethod(calledeRAPANSY
(evolutionary rapid panning analysis system)) [9] for screen-
ing of protease-regulating peptide aptamers based on mRNA
(and cDNA) display [10–12] and a substrate-function link
(SF-link) method [13]. This method was described in the
successful identiﬁcation of cathepsin E- (CatE-) inhibitory
peptide aptamers [9]. As a next step, we attempted to obtain
CatE-activity-enhancingpeptideaptamersatneutralpH(pH
7.4) using this method since CatE was reported to induce
apoptosis of cancer cells under physiological conditions (pH
7.4). In this process, CatE catalyzes the release of TRAIL2 International Journal of Peptides
(tumor necrosis factor-related apoptosis-inducing ligand)
without aﬀecting normal cells [14]. Thus, CatE-activity-
enhancing peptide aptamers that function at neutral pH may
be promising reagents for cancer therapeutics. Intriguingly,
a similar approach that utilizes a microenvironmentally
activated protease has been developed, and clinical trials
using protease-activated prodrugs for prostate cancer are
path-ﬁnding approaches in this ﬁeld [15].
In order to identify CatE-activity-enhancing peptide
aptamers at neutral pH, we ﬁrst developed an assay system
for measuring the unusual activity of cathepsin E at pH 7.4
instead of pH 4.5 and then performed the general scheme
of in vitro evolution (eRAPANSY) for obtaining protease-
activating peptides based on inverse SF-link selection. We
describe here the successful development of one promising
peptide aptamer (S3) that enhanced CatE-activity by up to
260% in vitro and which induced apoptosis in cancer cells
(HeLa). Through these experiments, we have demonstrated
and conﬁrmed the eﬀectiveness of this method for in vitro
evolution and its wide applicability.
2.MaterialsandMethods
2.1. Cathepsin E (CatE) and Its Substrate. Aﬂ u o r o -
genic substrate susceptible at neutral pH to the protease
cathepsin E, which usually functions at acidic pH, was
designed as per reference [16]: [Nma-Gly-Gly-Arg-Arg-
Ser-Gly-Thy-Cys-Gly(Dnp)-D-Arg-NH2]. The peptide was
custom-synthesized at Peptide Institute (Osaka, Japan) and
conﬁrmed to be an eﬀective substrate at pH 7.4. The peptide
was dissolved in dimethyl sulfoxide (DMSO) at 10mM and
stored in a deep freezer until use. The enzyme CatE was
prepared from rat spleen according to the method previously
described [17] and immobilized on N-hydroxysuccinimide-
activated sepharose beads (GE Healthcare, USA) using the
amine-coupling method and stored in, 100mM phosphate
buﬀe r( p H7 . 4 )a t4 ◦C.
2.2. CatE-Activity-Enhancement Assay. CatE-activation by
peptide aptamers was assayed by the method described
previously [9] but with a few modiﬁcations. Brieﬂy, the
CatE (20nM) solution preincubated with a peptide aptamer
in a 1:1 molar ratio in the selection buﬀer (50mM Tris-
HCl, 100mM NaCl, pH 7.4) at 25◦C for 10min. was
combined with the ﬂuorogenic substrate (5µM) and the
enzyme reaction performed at 37◦C for 1h. The reaction
product was measured by ﬂuorescence intensity at 440nm
with an excitation wavelength of 340nm using a ﬂuorescence
microplate reader, Inﬁnite 200 (Tecan, Japan). The percent-
age of activation (A) was calculated by ﬁtting the data to the
following equation:
A = 100 ×
Sf −Bf
Cf −Bf
[%a c t i v a t i o n ],( 1 )
where Sf represents the ﬂuorescence intensity of the positive
reaction consisting of the enzyme (CatE), the ﬂuorogenic
substrate, and a possible peptide activator; Cf is that of the
control reaction mixture consisting of CatE and ﬂuorogenic
substrate (without peptide activator); Bf is the background
ﬂuorescence of the negative reaction mixture consisting of
only the ﬂuorogenic substrate.
2.3. Primary and Secondary Library Constructions. The pri-
mary and the secondary libraries were constructed according
totheprotocolsdescribed in[9].In brief, theprimary library
was constructed by Y-ligation-based block shuﬄing (YLBS)
[19]. The secondary library was constructed by exploiting
the YLBS method with slight modiﬁcations. The peptide
sequences obtained from the primary library selection
were cluster-analyzed and used to design the subsequently
constructed blocks (Figure 2). Using these blocks, YLBS-
shuﬄing was performed (Table 1). The resultant library
containedallofthearbitrarilyshuﬄedblockswithadiﬀerent
number of blocks (1–4 blocks; Figure 2(b)), thus termed an
all-steps-all-combinations (ASAC) library. Prior to the in
vitro selection, the variable sequences were integrated into
the cDNA-tagged-SF-link peptide construct. The prepara-
tion of the construct was performed following the method
previouslyreported[9]andispartiallyappearinginFigure 1.
2.4. Selection of CatE-Activity-Enhancing Peptide Aptamers.
The cDNA displayed-SF-link construct having an interven-
ing CatE-substrate sequence (Figure 1)w a ss u b j e c t e dt ot h e
inverse SF-link selection method. An inverse function-based
selection strategy was adopted to obtain CatE-activating
peptides at neutral pH (pH 7.4) and is described below.
First, in order to remove the nonspeciﬁc binding peptides,
the cDNA-tagged SF-link-peptide library (see Figure 1)w a s
treated with the selection buﬀer (50mM Tris-HCl, 100mM
NaCl, 5mM MgCl2, pH 7.4) containing 5µLo fNHS-
activated sepharose beads (90µm mean particle diameter,
resuspended in 100% isopropanol) at 25◦C for 10min.
The supernatant containing unbound cDNA-tagged-SF-link
peptide molecules was collected after removing the beads
by spinning down and used in the succeeding experiment.
The cDNA-tagged-SF-link peptide library thus obtained was
incubated with CatE-immobilized beads (about 5pmol CatE
immobilized) at 25◦C for 10min. Those peptides which bind
to beads (in other words, peptides with aﬃnity for CatE),
were collected by spinning and immediately resuspended in
reaction buﬀer (50mM Tris-HCl, 1M NaCl, pH 7.4) and
incubatedat37◦Cfor1h.(1stRound),30min.(2ndRound),
or 15min. (3rd Round). The incubation time decreases as
the selection round progresses leading to enrichment of
rapidly cleaved species. The reaction was terminated by
adding 1mL of 5% trichloroacetic acid. The supernatant
expected to contain CatE-activators was collected, PCR-
treated, and used as the library for the next selection round.
The molecules thus selected were subjected to conventional
cloning, sequencing analyses, synthesis, and activity assay.
2.5. In Vitro Translation Synthesis and Chemical Synthesis of
Peptides. For the rapid synthesis of peptides, in vitro trans-
lation using the coding sequences of selected peptides wasInternational Journal of Peptides 3
Peptide synthesis → activity assay
Primary library
Secondary library
(CatE-bound bead)
CatE-binding peptides
(discard) Noncleaved
Pick up and PCR
(1) Initial DNA construct for primary peptide library with SF-link
(3) cDNA display and peptide library with cDNA-tagged SF-link
(4) Inverse SF-link selection
N  o 
Y  e s 
Yes
( d i s c a r d ) 
N  o n - s p e c i ﬁ c  b i n d i n g  t o  b e a d s 
m R N A  ·cD N A h  y b r i d  S F - l i n k  p e p t i d e 
( B e a d ) 
( d i s c a r d )  N o 
+ 2 5 ◦C 
C l o n i n g  → s e q u e n c i n g  → cl u s t e r i n g 
S e l e c t e d  C a t E - a c t i v i t y - e n h a n c i n g  p e p t i d e s 
( a ) 
( b ) 
( c ) 
( d ) 
C l e a v e d 
3 0 m i n 
6 0 m i n 
1 5 m i n 
P r o t e o l y t i c  r e a c t i o n  a t  3 7 ◦C
( e ) 
T 7  p r o m o t e r  P O U  H i s - t a g  X a 
5   
5    3   
3    C a t E  s u b s t r a t e  F L A G  P L B R 
V  a r i a b l e  r e g i o n 
V  a r i a b l e 
r e g i o n 
P u r o m y c i n 
( f )  R e s t a r t i n g  D N A  c o n s t r u c t  f o r 
s e c o n d a r y  p e p t i d e  l i b r a r y  w i t h 
S F - l i n k 
5 
5  3 
3 
(2) mRNA library and ligation with puromycin linker DNA
Figure 1: Schematic representation of the inverse SF-link selection method for screening of CatE-activity-enhancing peptides at neutral
pH. A DNA template construct for primary peptide library with SF-link is shown where YLBS-generated variable region is integrated with
T7 promoter, POU-domain, His-tag, Factor Xa sequences at upstream part, and further elongated with CatE substrate, FLAG, and PLBR
(Puromycin linker binding region) sequences at downstream part (step 1). DNA template library is transcribed into mRNA library followed
by ligation with Puromycin-linker DNA at the 3 -terminus end (step 2) and then converted into cDNA-displayed SF-link peptide products
which is composed of both the functional part (random peptide sequence) and CatE peptide substrate (step 3). Finally, inverse SF-link
selection (step 4) was performed using cDNA-tagged SF-link peptide library: (a) the nonspeciﬁc binding peptides were removed by NHS-
activated sepharose beads. (b) The CatE binding peptides were recovered at 25◦C after 10min. of incubation with CatE-bound beads. (c)
CatE-binding peptides were subjected to protease (CatE) cleavage at 37◦C with cutoﬀ incubation time in three successive rounds. (d) The
rapidly cleaved peptides (still attached to cDNA) were recovered, PCR-treated, and used for the next selection round. (e) Molecules selected
were subjected to cloning, sequencing, and clustering analysis. Some of the selected clones were peptide synthesized [18], analyzed for
activity, and conﬁrmed as CatE-activity-enhancing peptides. (f) The secondary library was generated using the primary library selection
products followed by the peptide library with cDNA-tagged SF-link generation and selection process as described in steps 2–4.4 International Journal of Peptides
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Figure 2: Surveying the building block peptides used for the secondary library. (a) Cluster analysis of the peptides selected from the primary
library, using ClustalW supported by DDBJ (DNA Data Bank of Japan). Consensus sequences are shown in bold. (b) Schematic drawing of
23 tetramer peptide blocks used for the secondary library construction by the ASAC (all-steps-all-combinations) method. In addition to the
blocks from the selected sequences (which also contain the SF-link construct), arbitrarily chosen blocks of (GGGG)/n were combined.
used[18].TheDNAconstructconsistingofthesequencesfor
the relevant peptide, the streptavidin-binding peptide, and
the protease factor Xa recognition site was prepared by way
of PCR and then transcribed and ﬁnally translated in vitro
according to the method previously reported in [18].
Those peptides which were cathepsin E-activating in
these experiments were subjected to commercial chemical
synthesis (BEX Corporation Ltd., Tokyo, Japan; SCRUM
Corporation Ltd., Tokyo, Japan). These peptides were puri-
ﬁed by HPLC and conﬁrmed by MALDI-TOF-MS.International Journal of Peptides 5
Table 1: Oligonucleotides used for the secondary library (ASAC) construction for CatE-activating peptides at neutral pH.
No. Nucleotide sequence (5  → 3 ) Size (nucleotides) Amino acid sequence of the block
Deﬁnitiona
GGCTCGCGAA TACTGCGAAG AAAGGTCGT (D5)2 9
GATCTCACTC CTTCGCAGTA TTCGCGAGCC (D3)3 0
Starting 5 /3  -halves for ASAC library
1D 5-GACCCATCCC CA/GACCCATCCC CA-D3 41/42 DPSP
2D 5-ATTATTATTA TT/ATTATTATTA TT-D3 41/42 IIII
3D 5-AAAGGCCCAC CA/AAAGGCCCAC CA-D3 41/42 KGPP
4D 5-CCATGCCCAT GC/CCATGCCCAT GC-D3 41/42 PCPC
5D 5-CCAGGCCCAC CA/CCAGGCCCAC CA-D3 41/42 PGPP
6D 5-TCCTGCTCCT GC/TCCTGCTCCT GC-D3 41/42 SCSC
7D 5-GTCGGGTGTG AC/GTCGGGTGTG AC-D3 41/42 VGCD
8D 5-TTCATGTACG TG/TTCATGTACG TG-D3 41/42 FMYV
9D 5-TGCTGCCCAC GC/TGCTGCCCAC GC-D3 41/42 CCPR
10 D5-CCAGGCATTA AA/CCAGGCATTA AA-D3 41/42 PGIK
11 D5-GACCCATCCC AA/GACCCATCCC AA-D3 41/42 DPSQ
12 D5-GGAGGACGGC GG/GGAGGACGGC GG-D3 41/42 GGRR
13 D5-TCCGCCACTT GC/TCCGCCACTT GC-D3 41/42 SGTC
14 D5-GCCGCCTTTA GA/GGCGGCTTTA GA-D3 41/42 GGFR
15 D5-CTGAAGGACT AC/CTGAAGGACT AC-D3 41/42 LKDY
16 D5-AAAGATGACG AT/AAAGATGACG AT-D3 41/42 KDDD
17 D5-TCCCCAATTA TT/TCCCCAATTA TT-D3 41/42 SPII
18 D5-CCACCACCAT GC/CCACCACCAT GC-D3 41/42 PPPC
19 D5-CCACCATCCT GC/CCACCATCCT GC-D3 41/42 PPSC
20 D5-TGTGACTTCA TG/TGTGACTTCA TG-D3 41/42 CDFM
21 D5-CCACGCCCAG GC/CCACGCCCAG GC-D3 41/42 PRPG
22 D5-TCCCAAATTA TT/TCCCAAATTA TT-D3 41/42 SQII
23 D5-GGAGGCGGAG GC/GGAGGCGGAG GC-D3 41/42 GGGG
aForsimplicity,thedevicesequencesaredeﬁnedandsymbolized(D5 andD3).FortheYLBSblockshuﬄing,5 -halfand3 -halfoligonucleotidesarehybridized
at their stem sequences (i.e., D5 and D3) and then ligated (for detail, see [19]).
2.6. Measurement of KD. An SPR instrument, Biacore 2000
(GE Healthcare, UK), was used for measuring KD for the
binding of cathepsin E and selected peptides. Cathepsin
E was immobilized onto Biacore sensor chip CM5 (GE
Healthcare, UK) by the amine-coupling method using an
Amine Coupling Kit (GE Healthcare, UK). Immobilization
of cathepsin E was performed using running buﬀer (50mM
sodium acetate, 100mM NaCl, pH 4.5). To determine
dissociation constants, four diﬀerent concentrations of
selected peptides were used for the interaction. The peptide
interactions were performed against CatE using the running
buﬀer (50mM Tris-HCl, 100mM NaCl, pH 7.4). After each
measurement, the chip surface was regenerated with 50mM
NaOH.Thebindingdatawereanalyzedwiththe1:1binding
with mass transfer model in the BIAevaluation software
version 4:1 (Biacore).
2.7. Measurement of Cell Viability. HeLa cells (1 × 104
cells/well in 96-well plate) were treated with cathepsin E
(7.7µM) alone and also in addition with peptide aptamer
(P3, selected from the primary library) using three diﬀerent
molar ratios of cathepsin E: peptide aptamer = 1:10; 1:100;
1:1000 in 100µL of serum-free Opti-MEM at 37◦Cf o r2 0h .
The cells’ viability was measured with the use of a Cell
Counting Kit-8 (Dojindo Molecular Technologies, Japan;
Figure 4(a)). The same method was also used for measuring
the eﬀect of cathepsin E and peptide aptamer (S3, selected
from the secondary library) on HeLa cells. The cell viability
was measured with Cell Counting Kit-F (Dojindo Molecular
Technologies, Japan; Figure 4(b)).
2.8. Statistics. A l ld a t aw e r ee x p r e s s e da sm e a n±SEMs. For
statistical analysis, two-way analysis of variance (Student’s t-
test) with repeated measures was used. P<. 05 was taken as
the level of statistical signiﬁcance.
3. Results
3.1. A General Scheme of In Vitro Evolution Method Based
on Inverse SF-Link Selection. To identify CatE-activity-
enhancing peptides at neutral pH, we adopted an in vitro
evolution method (eRAPANSY) [9] based on the inverse
SF-link selection approach which is shown schematically in
Figure 1. In brief, the overall strategy consists of the primary
library construction and selection (mass selection and clonal
selection) followed by construction and enrichment through6 International Journal of Peptides
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Figure 3: Selection of cathepsin E-activity-enhancing peptides at neutral pH. (a) Selection products from the primary library and the
secondary library. For both, the top 3 peptides are shown. For the activity assay, the peptides used here were synthesized by an in vitro
translation method [18]. Here, the ratio of CatE to an activity-enhancing peptide was 1/1 (= 20nM/20nM (see Materials and Methods
for detail). Each error bar represent average and standard deviation values of three independent experiments. (b) Biacore sensorgrams of
peptides, P3 (primary library selection product) and S3 (secondary library one) against cathepsin E (3.36mg/mL) immobilized onto sensor
chip CM5. To determine dissociation constants, four diﬀerent concentrations (25, 12.5, 6.3, and 3.2µMf o rP 3 and 50, 25, 12.5, and 6.3µM
for S3) of the peptides were subjected to the interaction. ∗P<. 08, ∗∗P<. 05, and ∗∗∗P<. 0003 compared with the control group CatE and
substrate only (without peptide activator), by Student’s t-test.International Journal of Peptides 7
Table 2: CatE-activating peptides (at neutral pH) obtained from the primary library (A) and the secondary library (B) selections.
Name Amino acid sequence (N→C) Size (a.a.) pI Hydropathy (GRAVYd) Activities (%) KD
Adp
a Asy
b
(A) Primary library selection
P1 (p2006) VGCDFMYV 8 3.8 1.3 118 ±3.2 129 ± 10 N. A. (∼10−5)c
P2 (p2005) KGPPPCPC 8 8.2 −0.7 128 ±20 110 ± 4
P3 (p3006) IEGRVGCDFMYVG 13 4.2 0.5 130 ±10 130 ± 53 .34 ×10
−7
(B) Secondary library selection
S1 (p4035) SPIISHIVGCDPPSCG 16 5.3 0.5 160 ±20 — —
S2 (p4043) PGIKPPPCIIIIG 13 8.6 1.07 180 ±10 144.5 ±11 N. A.c
S3 (p4038) IGCEERSFPNIIIIIG 16 4.3 0.9 260 ±10 168 ±33 . 8 9 x 1 0 −7
aAdp is the activity measured using the in vitro translated peptide.
bAsy is the activity measured using the chemically synthesized peptide. For detail, see [18].
cNot accurate; SPR-measured repeatedly but the values obtained were not suﬃciently reliable. A rough estimation is given in the parenthesis.
dGrand average of hydropathy value (source: http://www.bioinformatics.org/sms2/protein gravy.html).
selection of a secondary library (a peptide library generated
by block shuﬄing of all-step-all-combinations using the
primary library selection products).
In the mass selection (i.e., dealing with a population
of molecules as a whole), the variable sequences (possible
“functional” sequences) were integrated into the initial
DNA construct ﬂanked by the substrate peptide sequence
(step 1 in Figure 1). Namely, each peptide was attached
to the DNA molecule which consisted of coding regions
for T7 promoter, Kozak, His-tag, Factor Xa recognition
sequence, variable sequence, CatE substrate sequence, anti-
genic sequence for the FLAG antibody, and puromycin
linker binding region (PLBR; Figure 1). The cDNA display
method [12], a derivative of mRNA display [10, 11], was
applied to this DNA library to obtain the peptide library
with the cDNA-tagged SF-link. To prepare the cDNA display
construct, a puromycin linker DNA was bound to an mRNA
molecule through the hybridization with the PLBR sequence
(step 2 in Figure 1). The puromycin-linked mRNA thus
formed can covalently bind to the nascent peptide via the
puromycin, a mimic of an aminoacyl tRNA, generating the
mRNAdisplay construct.To increasethe stability, the mRNA
display construct was converted to the cDNA display one by
the action of reverse-transcriptase. The peptide library with
the cDNA-tagged SF-link construct thus obtained contains
a random peptide (functional part) and a CatE-substrate
sequence [9] (step 3 in Figure 1)a n dw a ss u b j e c t e dt o
the inverse SF-link selection (step 4a–4d, for details see
Materials and Methods) devised for screening of the CatE-
activity-enhancingpeptideaptamers.Theessentialdiﬀerence
between the SF-link selection method (to identify inhibitors
[9]) and the inverse SF-link selection method (to identify
activators) is that the noncleaved peptides were discarded
while the cleaved peptides were retained as shown in step 4c.
In the clonal selection (i.e., screening of the molecules
individuallyonaclone-by-clonebasis),thepeptideaptamers
thus obtained from mass selection were cloned, sequenced,
and cluster analyzed (step 4e). Some of clones were subjected
to in vitro peptide translation [18] and the CatE-enhancing
activity conﬁrmed in an activity assay as described in the
Materials and Methods. After the primary library generation
and selection, the secondary library generation and selection
results in a proven elevation in the activity of selected CatE-
peptide activators (step 4f).
3.2. CatE-Activity-Enhancing Peptide Aptamers Selected from
t h eP r i m a r ya n dt h eS e c o n d a r yL i b r a r y . The peptide
aptamers thus obtained from the primary library (P1,P 2,
and P3) enhanced the CatE-activity by around 10 to 30%
(measured using peptides obtained by in vitro translation
synthesis) and such activities were also conﬁrmed by using
chemical synthesis of peptides (Table 2(A)). Notably, the
peptide with the highest activity in the primary library
selection was an insertion-carrying peptide (P3)o f1 3a m i n o
acids while others are of normal size (octapeptide). The
resulting CatE-activity-enhancing peptide aptamers thus
obtained from the primary library were cluster-analyzed to
provide sequence information on possible functional blocks
which could be used for generating the secondary library
(ASAC library; Table 1;a n dFigure 2(a)). The secondary
library was constructed as shown in Figure 2(b) [9]. The
secondary cDNA-tagged SF-link peptide library thus con-
structed was subjected to the inverse SF-link selection as
described above (Figure 1). The selection products from this
librarydemonstratedhigheractivitythanthoseselectedfrom
the primary library (Figure 3(a) and Table 2). The average
increase in the CatE-enhancing activity of the top three hits
selected out of ∼50 clones sequence-analyzed was signiﬁcant
with peptides demonstrating more than 160% activity and
one peptide (S3) showing an activity increase of up to 260%
CatE activity (P<. 0003; Table 2), which is two-fold higher
activity than that (130%) of the best peptide (P3; P<. 05)
obtained from the primary library selection when measured
using in vitro translation synthesized peptide (Figure 3(a)).
However, such values are known to have a relatively large
ﬂuctuation [18] since the amount of the ﬁnal product
(peptide) generated by in vitro translation is an estimation
value based on the initial amount of the reactant due to their
very small n amount (∼pmole) [18]. Therefore, peptide (S3)
was chemically synthesized, and its CatE-enhancing activity8 International Journal of Peptides
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Figure 4: Eﬀect of CatE and peptide aptamers, (a) P3 and (b) S3,o nH e L ac e l l s .H e L ac e l l s( n = 1 × 104) in 96-well plates were incubated
overnight with, cathepsin E and peptide (P3 or S3) mixture at three diﬀerent molar concentration ratios (cathepsin E:peptide = 1:10;
1:100; 1:1000). After 20hours of incubation at 37◦C, cells were assayed for viability using a Cell Counting Kit-8 (measuring the absorbance
at 450nm) and Cell Counting Kit-F (CCK-F) measuring the ﬂuorescence at 535nm (excitation at 485nm) using a microplate reader. Error
bars represent average and standard deviation values of three independent experiments. ∗P<. 4, ∗∗P<. 05, and ∗∗∗P<. 007 compared
with the control group (only CatE-treated cells) by Student’s t-test.
was measured (Table 2(B)). The value thus obtained was
lower than that obtained from in vitro translation, which is a
trend generally observed with this approach [18]. As a result,
a higher activity (168%) than the best peptide in the primary
screen (130%) was conﬁrmed, proving the steady rise in
the activity of peptides in this approach. The dissociation
constant of the peptide (S3)w a sf o u n dt ob e3 .89 × 10
−7M
by the SPR method, thus showing a relatively strong binding
aﬃnity (Table 2(B) and Figure 3(b)). The selection thus
performed using the inverse SF-link method was able to
identifyCatE-activity-enhancingpeptideaptamersatneutral
pH (Figure 1 and Table 2), indicating the eﬀectiveness of the
inverse SF-link selection method. The eﬀectiveness of the
secondary library selection is clearly shown in Figure 3.
3.3. Evaluation of Biological Activity of Selected Peptide
Aptamers in Cells. In order to evaluate the activities of
selected peptides (P3 and S3 obtained from the primary and
the secondary libraries, resp.; Table 2), we next tested the
combined eﬀect of CatE and selected peptide aptamers on
HeLa cells. The cells were treated with CatE alone or with
CatE and peptide aptamers (P3 and S3) in a dose-dependent
manner. Any decrease in cellular viability was analyzed (for
details see Material and Methods). Cells treated with CatE
and a peptide aptamer, P3 or S3, at a molar ratio of 1:100
showed around a 1.5- and 3-fold increase in the level of
apoptosisincomparisontocellstreatedwithCatEalone(P<
.05; Figure 4), respectively. These positive results corroborate
our current approach of using an in vitro evolution method
modiﬁed with the inverse SF-link selection for identifying
protease activity-enhancing peptide aptamers.
4. Discussion
CatE is reported to have the ability to induce apoptosis
in cancer cells [14], a process which must occur under
physiological conditions (i.e., at neutral pH). In this study,
the activity of CatE, which is known to usually function
at acidic pH (pH 4.5), was measured at neutral pH (pH
7.4) using a novel substrate as described in Materials and
Methods. The peptides that can enhance CatE activity under
the assay conditions were selected as shown in Table 2.
In this paper, we address two subjects: (i) selection of
activity-enhancing, rather than inhibiting peptides and (ii)
performance of evolution, not only selection, of peptides
(proteins). Both points are discussed here. It is well known
that ﬁnding activating reagents is more diﬃcult than ﬁnding
inhibitory ones since the latter has the clear target of the
substrate-binding site. Therefore, a lot of inhibitory reagents
have been developed but far fewer activating ones [4, 5, 20,
21]. The SF- (substrate-function-) link method developed
recently [13] has the potential to select protease-activating
peptidesifitisoperatedintheinversemodeowingtoitscon-
struction design (see Figure 1), and this technique has been
successfully exploited for the ﬁrst time in this paper. This has
resulted in the ﬁnding that the majority of selected peptides
are CatE-activating species (partly shown in Table 2). This
is noteworthy since starting with the same library (the
aﬃnity selection product), we could obtain the opposite
type of functional peptides (activators) by adopting the
inverse mode of function-based selection using the SF-link
method in which swiftly cleaved oﬀ cDNA-tagged SF-link
peptidemolecules(whichareaconjugateofinformationand
functional molecules, see Figure 1 step 4c, were collected).International Journal of Peptides 9
The cathepsin E-activity-enhancing peptides (P1,P 3,S 2,a n d
S3) identiﬁed herein contain common features being com-
p o s e do fac h a r g e dh e a dg r o u pa n dal a r g eh y d r o p h o b i c
tail (detergent-like peptides). The activation may be due
to some combination of enzyme stabilization in solution,
loosening of the protein secondary structure, or alteration of
adsorption of the enzyme to the surface of containers during
the enzyme reaction [22]. We need to further investigate
these possible activation mechanisms. Interestingly, in the
SPR measurements, the secondary library selection resulted
in obtaining peptides with increased activity without much
change in aﬃnities (similar KD values for P3, from the
primary library, and S3, from the secondary library and
see Table 2 and Figure 3(b)). Those peptides (P1 and S2)
which contain a single charged amino acid embedded in
hydrophobic ones showed abnormal behaviors in the SPR
measurement (data not shown), probably indicating strong
nonspeciﬁc (hydrophobic) binding to the supporting plate
even though a surface-blocking agent (1M ethanolamine-
HCl, pH 8.5) was used. Therefore, these peptides may
need to be modiﬁed into a more soluble structure for
advanced applications such as a drug seed. In addition,
the evaluation of selected CatE-activity-enhancing peptides
on cells provides deﬁnitive proof that our current in vitro
evolution method based on the inverse SF-link selection is
eﬀective.
In addition, this study also conﬁrms the eﬀectiveness of
the eRAPANSY method that allows the molecular library
to progress towards higher activity. Although it may be
early to draw the conclusion that this is a proven method
for obtaining much improved molecules, the following can
be stated safely: the primary library selection is equiva-
lent to a search for module-like peptides out of a huge
number of meaningless peptides while the construction of
the secondary library is analogous to module-shuﬄing (or
exon shuﬄing), which is assumed to have worked during
the evolution of proteins [23]. An interesting issue to be
addressed in the future concerns the size of blocks (or
module) which holds meaning (or function), though, in
this study, it was rather arbitrarily determined to be a
tetrapeptide, which was ultimately eﬀective. In other words,
theway,bywhichnaturalproteinsevolved,holdspromisefor
the artiﬁcial development of proteins. According to recent
genome analysis, during the evolution of life, the recom-
bination mechanism strongly governed and contributed to
the generation of novel proteins [24, 25]. This fact is also
supportive of our approach where drastic recombination
of sequences (block shuﬄing) has been employed together
with point mutation in the construction of the secondary
library.
In conclusion, this study has succeeded in introducing
an assay system for CatE activity at neutral pH (pH 7.4)
and in obtaining CatE-activating peptides by employing the
successive in vitro evolution method (eRAPANSY) based on
inverse SF-link selection. These results endorse the notion
that the method employed here is applicable for obtaining
activity-enhancing peptides for proteases at large. Such a
notion, of course, needs to be strengthened by succeeding
studies adopting this method.
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